Standards+of+Conduct

**Global Standards of Conduct**

Since Johnson & Johnson is a global corporation that has over 250 subsidiary companies with operations in over 57 countries then this organization has a global presence. Johnson & Johnson adheres to the highest ethical standards in the work that is conducted in their laboratories and in the clinical research with people, across their Family of Companies. In addition, they review their research policies to ensure they’re aligned with ethical standards around the world.


 * __Standards of Conduct__**
 * 1. Ensure international operations don’t lead to the displacement of existing communities**

__ Johnson & Johnson Paid Bribes Overseas: Feds __ J&J will pay $70 million in fine because some of its employees paid “bribes” to health care providers. Company has admitted their wrongdoing but good thing that company fully cooperated to unravel the corruption. Workers paid bribes in Greece, Poland and Romania and few J&J subsidiaries also involved in this scandal. J&J timely disclosure and cooperation appreciated by Justice Department and court said that J&J cooperation is “extraordinary”. More than $48 million of the fines will go to the Securities and Exchange Commission. The rest will go to the Department of Justice.

[]

__J&J Tylenol incident, 7 people died.__

J&J suspected product Tylenol tempering on store shelves because in this incident 7 peoples have been died in Chicago in 1982 using extra strength capsules, on the hand J&J proudly claimed and in their credo:

//“We believe our first responsibility is to the doctors, nurses and patients, to mothers and fathers and all others who use our products and services. In meeting their needs we must do everything of high quality.”//

[|**http://www1.hrpa.ca/NR/rdonlyres/E0A272D1-C42E-40E1-B1DF-7E33C9125402/0/%20Corporate_Social_Responsibility.pdf**]

J&J follows consistent principles relative to the labour and employment practices and they have set global guidelines for their company. They communicate with employees and whenever possible, partner with them to achieve desirable competitive outcomes. In every instance, we must first ensure that our policies and actions are in full compliance with the laws and regulations of the respective countries in which we operate.
 * 2. Ensure fair labour practices are followed**

__Johnson & Johnson sued again, this time from the executive suite__

J&J fired former chief medical officer because he was voicing product safety concerns and pushing to company for product recalls. Employee is filed a claim in discrimination lawsuit and but company denies the allegations. The pharmaceutical industry, like large insurers and retailers in recent years, faces a storm of employee lawsuits over failure to pay overtime, age discrimination and other unfair labour practices. [|http://www.businessmanagementdaily.com/articles/5273/1/Johnson--Johnson-sued-again-this-time-from-the-executive-suite/Page1.html#]

The company regularly communicates with employees about the policy and supporting programs. Generally, the Global Health department sends out communications to the local management, who then cascades the messages to the appropriate staff. The Global Health department also provides handouts to be used at local meetings or "lunch and learn" sessions. In many cases, Johnson & Johnson uses the strong resources from local governments to promote country-specific programs, especially in the UK, India and China, where there are very visible governmental initiatives to help people stop using tobacco. In such cases, the government promotes tobacco-cessation efforts because they absorb more health care costs than do governments of other countries such as the U.S. Johnson & Johnson seeks to leverage these efforts to reach out to their employees about the benefits of tobacco cessation.
 * 3. Demonstrate sensitivity to local cultures and customs**

__J&J pleads guilty to illegal marketing of psychiatric drugs__
 * 4. Comply with human rights standards**

J&J signed a settlement of $81 million for government allegation that J&J is illegally marketing its one of the product (anti-seizure) drug which uses for disorder and alcohol addiction treatment. J&J had paid up to $3,000 per day plus expenses to doctors who were running their marketing campaign. []

__J&J Duped South Carolina Doctors Over Risperdal__

J&J will pay $360 million in penalties because they made misleading claims about effectiveness of their products “Risperdal’s health risks” which affects 7,000 doctors and violated consumer protection laws in South Carolina. The drug-maker used “unfair and deceptive acts” in a marketing campaign for getting signing off on Risperdal for mental-health patients from doctors. []

The Wall Street Journal U.S. Edition, Saturday April 9, 2010 []
 * J&J Deficiencies in Manufacturing Operations**

J&J’s recalled more than 384,000 insulin-pump cartridges in the U.S. and France, saying __they have the potential to leak and give a too-low dose__.

In February, J&J announced that they are pulling at least 395 injection pens preloaded with rheumatoid-arthritis drug __because injection didn’t deliver a full dose of the drug__.

In March 2011, the company __recalled leaky insulin cartridges__, as after review their operations they found quality deficiencies and decided that they’ll hire an expert to investigate the violations of good manufacturing practices and to develop a plan to avoid this issue in the future.

J&J already recalled early week 70,000 preloaded syringes with its inject-able anti-psychotic drug __because injection’s cracks__ could lead to infections or under-dosing in users.

In January J&J made 43 million Tylenol bottles __that manufactured in the plant where equipments were not properly cleaned__ and they also pull 4 million units of another product (Rolaids) __due to wrong label__.

J&J’s another product (Evolence) has a very poor track record in Europe. __J&J intentionally paid very big amount to their US Consultants for saying that it is wonderful filler__, in-fact that filler produce allergy and injected like cement.

Since 2004, majority of __European physicians refused to use it due to its poor performs__ and then J&J admitted that US Consultants were wrong and J&J approved that product without FDA plastic surgery panel’s advice and then J&J stopped selling that product in 2009.